Schistosomiasis Among Female Migrants in Non-endemic Countries

Schistosomiasis among migrant populations in Europe is an underdiagnosed infection, yet delayed treatment may have serious long-term consequences. In this study we aimed to characterize the clinical manifestations of Schistosoma infection among migrant women, and the degree of underdiagnosis. We car...

Descripción completa

Detalles Bibliográficos
Autores: Roure, Silvia|||0000-0002-7982-0890, Pérez-Quílez, Olga, Vallès, Xavier|||0000-0002-4445-1490, Valerio, Lluís|||0000-0003-3152-5523, López-Muñoz, Israel|||0000-0002-1233-2606, Soldevila Langa, Laura|||0000-0002-3324-0225, Torrella, Ariadna, Fernandez Rivas, Gema|||0000-0003-4854-5934, Chamorro, Anna, Clotet Sala, Bonaventura|||0000-0003-3232-4598
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:258136
Acceso en línea:https://ddd.uab.cat/record/258136
https://dx.doi.org/urn:doi:10.3389/fpubh.2022.778110
Access Level:acceso abierto
Palabra clave:Female genital schistosomiasis
Imported schistosomiasis
Migrants females
Neglected
Migrants population in Europe
Schistosomiasis in non-endemic countries
Descripción
Sumario:Schistosomiasis among migrant populations in Europe is an underdiagnosed infection, yet delayed treatment may have serious long-term consequences. In this study we aimed to characterize the clinical manifestations of Schistosoma infection among migrant women, and the degree of underdiagnosis. We carried out a prospective cross-sectional study among a migrant population living in the North Metropolitan Barcelona area and coming from schistosomiasis-endemic countries. We obtained clinical, laboratory and socio-demographic data from electronic clinical records, as well as information about years of residence and previous attendance at health services. Blood sample was obtained and schistosomiasis exposure was assessed using a specific ELISA serological test. Four hundred and five patients from schistosomiasis-endemic regions were screened, of whom 51 (12.6%) were female. Seropositivity prevalence was 54.8%, but considering women alone we found a prevalence of 58.8% (30 out of 51). The median age of the 51 women was 41.0 years [IQR (35-48)] and the median period of residence in the European Union was 13 years [IQR (10-16)]. Schistosoma -positive women (N = 30) showed a higher prevalence of gynecological signs and symptoms compared to the seronegative women (96.4 vs. 66.6%, p = 0.005). Among seropositive women, the median number of visits to Sexual and Reproductive Health unit prior to diagnosis of schistosomiasis was 41 [IQR (18-65)]. The high prevalence of signs and symptoms among seropositive women and number of previous visits suggest a high rate of underdiagnosis and/or delayed diagnosis of Schistosoma infection, particularly female genital schistosomiasis, among migrant females.